Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Younossi, Zobair M, Ratziu, Vlad, Loomba, Rohit, Rinella, Mary, Anstee, Quentin M, Goodman, Zachary, Bedossa, Pierre, Geier, Andreas, Beckebaum, Susanne, Newsome, Philip N, Sheridan, David, Sheikh, MuJournal:
The Lancet
DOI:
10.1016/S0140-6736(19)33041-7
Date:
December, 2019
File:
PDF, 676 KB
2019